You are here: Home Educational material

Educational material

by keyword:
Sort by: Date added | View count

The PCA3 Score is not affected by dutasteride; analysis of the REDUCE trial

This poster was presented by R Rittmaster at the ASCO 2010 Genitourinary Cancers Symposium, 5-7 March 2010, San Francisco, California, USA
Submitted by on 2010/07/22



Analysis of REDUCE trial confirms that the PCA3 Assay can help guide repeat biopsy decisions

This poster was presented by J Groskopf J at the ASCO 2010 Genitourinary Cancers Symposium, 5-7 March 2010, San Francisco, California, USA
Submitted by on 2010/07/22



Feasibility of the PCA3 urine test in a community-based prostate cancer screening setting

This poster was presented by Dr. van Bokhoven at the 2009 annual meeting of the AUA, 25-30 April, Chicago, Illinois, USA
Submitted by Ismar Healthcare on 2009/10/13



Utility of CapDetectâ„¢ PCA3 Score with other factors to improve prediction of prostate biopsy outcome

This poster was presented by Dr. Amberson at the 2009 annual meeting of the American Urological Association (AUA), 25-30 April, Chicago, Illinois, USA
Submitted by Ismar Healthcare on 2009/09/25



More...